Pay in 4 interest-free payments of $24.40 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Cells treated with MPI-0479605 undergo aberrant mitosis
and MDA-MB-361 cells with IC50 of 46 nM
Viruses are especially susceptible
This is consistent with previous reports indicating that Sotrastaurin inhibits ERK1/2 phosphorylation in GNAQ mutant cell lines
Vildagliptin 598 Cells treated with MPI-0479605 undergoVildagliptin (also known as LAF237 and Zomelis) is an oral anti hyperglycemic agent (anti diabetic drug) of the new dipeptidyl peptidase 4 (DPP 4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP 1 and GIP by DPP 4, allowing GLP 1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas. Vildagliptin has been shown to reduce
US$ 129.50
US$ 412.50
US$ 121.00
US$ 302.50
US$ 109.95
US$ 412.50
US$ 412.50